These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17568996)
1. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells. Carapancea M; Cosaceanu D; Budiu R; Kwiecinska A; Tataranu L; Ciubotaru V; Alexandru O; Banita M; Pisoschi C; Bäcklund ML; Lewensohn R; Dricu A J Neurooncol; 2007 Dec; 85(3):245-54. PubMed ID: 17568996 [TBL] [Abstract][Full Text] [Related]
2. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines. Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056 [TBL] [Abstract][Full Text] [Related]
3. Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma. Simpson AD; Soo YWJ; Rieunier G; Aleksic T; Ansorge O; Jones C; Macaulay VM Br J Cancer; 2020 Mar; 122(5):624-629. PubMed ID: 31857716 [TBL] [Abstract][Full Text] [Related]
4. Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism. Cosaceanu D; Budiu RA; Carapancea M; Castro J; Lewensohn R; Dricu A Oncogene; 2007 Apr; 26(17):2423-34. PubMed ID: 17043647 [TBL] [Abstract][Full Text] [Related]
5. The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma. Alexandru O; Purcaru SO; Tataranu LG; Lucan L; Castro J; Folcuţi C; Artene SA; Tuţă C; Dricu A Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329222 [TBL] [Abstract][Full Text] [Related]
6. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit. Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells. Isebaert SF; Swinnen JV; McBride WH; Haustermans KM Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290 [TBL] [Abstract][Full Text] [Related]
9. Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis. Steinbach JP; Eisenmann C; Klumpp A; Weller M Biochem Biophys Res Commun; 2004 Aug; 321(3):524-30. PubMed ID: 15358139 [TBL] [Abstract][Full Text] [Related]
10. GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo. Zhou X; Shen F; Ma P; Hui H; Pei S; Chen M; Wang Z; Zhou W; Jin B Mol Med Rep; 2015 Oct; 12(4):5641-6. PubMed ID: 26238593 [TBL] [Abstract][Full Text] [Related]